Karen Massey
Chief Operating Officer bei ARGENX SE
Profil
Ms. Karen Massey is a Chief Operating Officer at argenx SE.
Ms. Massey was previously employed as a Senior Vice President-Product Development by Genentech, Inc. and a Principal by Pfizer Inc. She received her undergraduate degree from The University of Sydney and an MBA from The Leonard N Stern School of Business.
Aktive Positionen von Karen Massey
| Unternehmen | Position | Beginn |
|---|---|---|
| ARGENX SE | Chief Operating Officer | 13.03.2023 |
Ehemalige bekannte Positionen von Karen Massey
| Unternehmen | Position | Ende |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Ausbildung von Karen Massey
| The University of Sydney | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ARGENX SE | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
